New poll reveals Americans' mixed views on weight-loss drugs for obesity treatment, especially regarding teen use.
Suzetrigine prevents pain signals from reaching the brain and doesn't give an opioid-like high, making it non-addictive—but it's expensive.
The drug represents a new pathway to treating people with pain due to surgeries or traumatic injuries, avoiding the addictive ...
Journavx is the first and only approved non-opioid oral painkiller and the first new class of pain medicine approved in more ...
A chocolate recall was recently upgraded to warn consumers of a potential to “cause serious adverse health consequences of death.” ...
I’m Conway Gittens reporting from the New York Stock Exchange. Here’s what we’re watching on TheStreet today. Wall Street ...
The new drug will carry a list price of $15.50 per pill, making it many times more expensive than comparable opioids.